INTERNATIONAL PATENT: DUKE UNIVERSITY FILES APPLICATION FOR "RECOMBINANT HIV-1 ENV IMMUNOGENS FOR ELICITING FUSION PEPTIDE DIRECTED ANTIBODIES"

GENEVA, Jan. 7 -- DUKE UNIVERSITY (2812 Erwin RoadSuite 406DURHAM, North Carolina 27705) filed a patent application (PCT/US2025/034975) for "RECOMBINANT HIV-1 ENV IMMUNOGENS FOR ELICITING FUSION PEPTIDE DIRECTED ANTIBODIES" on Jun 24, 2025. With publication no. WO/2026/006260, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ACHARYA, Priyamvada (c/o Duke University2812 Erwin RoadSuite 406DURHAM, North Carolina 27705), LELLA, Muralikrishna (c/o Duke University2812 Erwin RoadSuite 406Durham, North Carolina 27705), THAKUR, Bh...